Novo Holdings is a Danish private limited liability company wholly owned by the Novo Nordisk Foundation. It is the holding company of the Novo Group, comprising Novo Nordisk A/S, Novozymes A/S and NNIT A/S, and is responsible for managing the Foundation’s assets.

In addition to being the major shareholder in the Novo Group companies, Novo Holdings invests the wealth of the Foundation in two key categories: 1. Life Science Investments, which includes investing in life science companies across all stages of development; and 2. Financial Investments, which manages a diversified portfolio of equity and fixed income securities.

It is the vision of Novo Holdings to be recognized as a world-leading life science investor with a focus on creating long-term value.

Media contact

Christian Mostrup Scheel
Senior Press Officer
+ 45 306 74805
[email protected]